Expert Commentary

New and promising GSM treatments, more clinical takeaways from NAMS 2018

Author and Disclosure Information

Dr. Richard-Davis served as the Scientific Program Chair of the 2018 North American Menopause Society (NAMS) Meeting. In this audiocast she highlights several clinical takeaways from the meeting, including:

  • new treatments for uterine fibroids
  • the telomere’s role in helping women live longer lives, and protective (estrogen) and adverse (stress, obesity) factors affecting telomere length that patients can address through a healthy lifestyle
  • the legal risks of not screening for hereditary cancer
  • obesity prevention, treatment, and long-term lifestyle changes during menopause
  • new and on-the-horizon therapies for GSM
  • much more.


Learn more about NAMS:

Next Article: